Vertex Pharmaceuticals Incorporated Forecast and Target Price
$468.66
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast
Currently 38 wall-street analysts regularly analyze the financials of Vertex Pharmaceuticals Incorporated on a frequent basis to provide recommendations along with target share price. 38 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Incorporated (VRTX) have a share price target of $499.87. This median of share price forecast represents a 6.66% upside from the latest price of $468.66 as on 13.07.25.
Vertex Pharmaceuticals Incorporated (VRTX) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Vertex Pharmaceuticals Incorporated (VRTX) share price will touch around $499.87 in next 12-months.
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Vertex Pharmaceuticals Incorporated's share price and its median forecast price. As on 13.07.25, the difference is -9.55%
Vertex Pharmaceuticals Incorporated (VRTX): Difference between Current Price & Median Forecasted Price
Vertex Pharmaceuticals Incorporated (VRTX) Share Price : Analyst Recommendation
Based on 38 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 16 | 16 | 16 |
| Outperform | 10 | 10 | 10 |
| Hold | 8 | 10 | 10 |
| Underperform | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 |